September 16, 2003

A pharmaceutical composition is provided containing an admixture of phenytoin sodium and an erodible matrix which extends the release of the phenytoin sodium over about a two hour period. The erodible matrix comprises binder(s) and diluent(s) which control the release of drug from the pharmaceutical composition. The erodible matrix can further comprise an alkaline pH modifier.

18

September 16, 2003

09/852,761

May 11, 2001

424/451   424/464 424/469 424/484 424/485 424/486 424/487 424/488 514/770 514/772.3 514/773 514/774 514/777 514/778 514/779 514/781 514/782 514/783

A61K   9/48   (20060101)   A61K   9/20   (20060101)  

This application is a continuation-in-part of U.S. Ser. No. 09/255,705, filed Feb. 23, 1999 U.S. Pat. No. 6,274,168B1.

424/451   424/464   424/484   424/485   424/486   424/487   424/488   424/489   424/468   424/465   424/456   424/469